Amgen AMGN Risk & Quality report
Healthcare & Pharma · September 2026 edition, published 2026-09-29.
Amgen scored 0-100 on three pillars: valuation (35%), financial health (35%) and growth (30%), each explained card by card, with the latest quarter, catalysts against risks and a written verdict. Every figure is reconciled against live market data before the edition ships, and the edition is rebuilt every month.
Free: the company's financials
Ten years of Amgen's revenue, margins, net income, free cash flow, cash and debt, and revenue by segment, read from its SEC filings: Amgen financials.